Literature DB >> 15231442

Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment.

Meena Vythilingam1, Eric Vermetten, George M Anderson, David Luckenbaugh, Eric R Anderson, Joseph Snow, Lawrence H Staib, Dennis S Charney, J Douglas Bremner.   

Abstract

BACKGROUND: Depression has been linked to stress, memory deficits, and hypercortisolemia. However, the relationships between depression, hippocampal structure and function, and cortisol levels are unclear and the effects of antidepressant treatment on the measures are not well studied.
METHODS: Whole hippocampal volume, performance on verbal and visual declarative memory function and cortisol status was evaluated in 38 subjects with major depressive disorder (MDD) and 33 healthy subjects. All measures were repeated in a subgroup (n = 22) of depressed patients after successful selective serotonin reuptake inhibitor (SSRI) treatment.
RESULTS: Hippocampal volume was not significantly different between patients with untreated MMD and healthy subjects, after controlling for whole brain volume, age and gender. However, depressed subjects had significantly greater deficits in delayed memory and percent retention on the verbal portion of the Wechsler Memory Scale-Revised (WMS-R) compared with healthy subjects, without significant differences in visual memory, attention, vigilance, or distractibility. Baseline plasma or urinary free cortisol (UFC) was not related to either hippocampal volume or memory deficits. Successful treatment with antidepressants did not change hippocampal volume but did result in a significant improvement in memory function and a reduction in UFC excretion.
CONCLUSIONS: Medication-free nonelderly depressed outpatients without alcohol dependence or adverse experiences in childhood had normal hippocampal volume. Focal declarative memory deficits in depression supported localized hippocampal dysfunction in depressed patients. Treatment with antidepressants significantly improved memory and depression but did not alter hippocampal volume, suggesting that antidepressants may improve hippocampal function in the absence of detectable structural changes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15231442     DOI: 10.1016/j.biopsych.2004.04.002

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  116 in total

1.  Depressive symptoms, antidepressant use, and brain volumes on MRI in a population-based cohort of old persons without dementia.

Authors:  Mirjam I Geerlings; Adam M Brickman; Nicole Schupf; Davangere P Devanand; José A Luchsinger; Richard Mayeux; Scott A Small
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

2.  Survey of protocols for the manual segmentation of the hippocampus: preparatory steps towards a joint EADC-ADNI harmonized protocol.

Authors:  Marina Boccardi; Rossana Ganzola; Martina Bocchetta; Michela Pievani; Alberto Redolfi; George Bartzokis; Richard Camicioli; John G Csernansky; Mony J de Leon; Leyla deToledo-Morrell; Ronald J Killiany; Stéphane Lehéricy; Johannes Pantel; Jens C Pruessner; H Soininen; Craig Watson; Simon Duchesne; Clifford R Jack; Giovanni B Frisoni
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

3.  Fluoxetine protects against amyloid-beta toxicity, in part via daf-16 mediated cell signaling pathway, in Caenorhabditis elegans.

Authors:  Roongpetch Keowkase; Marwa Aboukhatwa; Yuan Luo
Journal:  Neuropharmacology       Date:  2010-04-24       Impact factor: 5.250

4.  Reduced hippocampal volume in drug-free depressed patients.

Authors:  Canan Saylam; Hülya Uçerler; Omer Kitiş; Erol Ozand; Ali Saffet Gönül
Journal:  Surg Radiol Anat       Date:  2006-01-04       Impact factor: 1.246

5.  A closer look at siblings of patients with schizophrenia: the association of depression history and sex with cognitive phenotypes.

Authors:  Krista M Wisner; Brita Elvevåg; James M Gold; Daniel R Weinberger; Dwight Dickinson
Journal:  Schizophr Res       Date:  2010-10-28       Impact factor: 4.939

6.  Bilateral hippocampal volume increases after long-term lithium treatment in patients with bipolar disorder: a longitudinal MRI study.

Authors:  Kaan Yucel; Margaret C McKinnon; Valerie H Taylor; Kathryn Macdonald; Martin Alda; L Trevor Young; Glenda M MacQueen
Journal:  Psychopharmacology (Berl)       Date:  2007-08-20       Impact factor: 4.530

Review 7.  Remodeling of axo-spinous synapses in the pathophysiology and treatment of depression.

Authors:  P Licznerski; R S Duman
Journal:  Neuroscience       Date:  2012-10-02       Impact factor: 3.590

8.  A shared effect of paroxetine treatment on gray matter volume in depressive patients with and without childhood maltreatment: A voxel-based morphometry study.

Authors:  Xiao-Wen Lu; Hua Guo; Jing-Rong Sun; Qiang-Li Dong; Fu-Tao Zhao; Xu-Hong Liao; Li Zhang; Yan Zhang; Wei-Hui Li; Ze-Xuan Li; Tie-Bang Liu; Yong He; Ming-Rui Xia; Ling-Jiang Li
Journal:  CNS Neurosci Ther       Date:  2018-09-12       Impact factor: 5.243

9.  Hippocampal changes associated with early-life adversity and vulnerability to depression.

Authors:  Uma Rao; Li-Ann Chen; Anup S Bidesi; Mujeeb U Shad; M Albert Thomas; Constance L Hammen
Journal:  Biol Psychiatry       Date:  2009-12-16       Impact factor: 13.382

10.  Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies.

Authors:  P Cédric M P Koolschijn; Neeltje E M van Haren; Gerty J L M Lensvelt-Mulders; Hilleke E Hulshoff Pol; René S Kahn
Journal:  Hum Brain Mapp       Date:  2009-11       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.